GBM patients with PTEN mutations, regardless of the type or residue, had increased incidence of the combined type of recurrence pattern (30.1% with PTEN mutations vs. 18.3% in PTEN-WT, P-value = 0.071, Fisher’s exact test) (Supplementary Fig. S12). Here, PTEN is linked to glioblastoma.